Thermo Fisher Scientific
The numbers and complexities of molecules that are screened and quantified in a clinical research laboratory continue to grow at a significant rate. Molecule types span between small and large, thus adding to the challenges typically faced in developing robust, reliable, and reproducible analytical methods.
Liquid chromatography, coupled to mass spectrometry, has been a popular technology owing to its specificity and selectivity while achieving sensitivity and reproducibility requirements. This GEN webinar will focus on demonstrating the capabilities of the new generation Thermo Scientific™ Orbitrap Exploris mass spectrometry platforms and how they can be capitalized to address challenging analytical experiments in the domain of protein quantitation. Moreover, our presenters will discuss the role of mass spectrometry in protein quantification with relation to antidoping, infectious disease, and potential disease biomarker discovery.
Debadeep Bhattacharyya, PhD, Sr. Manager, Marketing, Clinical and Forensic
Yu Zhou, PhD, Senior Application Scientist
* Required field